📺 Watch on YouTube and Spotify

Unlock the future of agtech and CRISPR with this deep dive into the world of soybean innovation and next-gen crop defense! Matt Begeman, a key voice from Confluence Genetics, unveils how his team is driving breakthroughs in seed genetics and leveraging cutting-edge technologies like CasClear. From transforming the profitability and sustainability landscape for growers to exploring the epic potential of CRISPR-based antimicrobials and cell-specific cancer therapies, this episode journeys across the science and strategy shaping global food and health systems.

Listen in to discover:

The intricate challenges and opportunities facing modern soybean growers
How AI and advanced breeding accelerate development of nutrient-rich, high-value crops
The story behind CasClear and its powerful implications for agriculture—and even cancer treatment
Why data, partnerships, and strategic tech licensing are changing the game

If you’re passionate about the intersection of biology, technology, and agriculture, this episode is packed with thought-provoking insights you won’t want to miss!

5 Key Takeaways

Take your agricultural strategy to the next level with these essential insights:

AI-driven breeding models like CropOS can significantly accelerate soybean variety development and optimize desired traits—embrace technology to boost your crop outcomes.
Creating higher-value soybean products with specialty traits unlocks premium markets for growers—seek out partnerships to increase your profitability per acre.
Gene editing and CRISPR-based innovations, such as CasClear, are expanding possibilities for crop protection and quality—stay informed and engaged with cutting-edge solutions.
Gathering and leveraging high-quality, connected sequence and phenotype data is key to successful breeding and product innovation—invest in your data strategy.
Strategic collaborations and technology licensing can help expand the reach of impactful platforms—consider partnerships to amplify innovation and business growth.

Memorable Quotes

"So if we could take our CasClear technology, design it specifically for their cancer, deliver it to that individual, and basically deliver cell-specific chemotherapy where it only destroys the cancer cells and leaves all the normal cells intact. That's the conceptual idea we've built with CasClear in the oncology space."

"Our goal is to enable as many different companies to use this technology as we can because I can't work on soybeans, antimicrobials, and oncology all at the same time. We've really got to partner with other companies to make this successful."

"If you have decades worth of phenotype data but you've never sequenced your populations or understand your population structure, you're also kind of stuck. You've got to really pull both of these together to enable those AI tools to really drive your breeding organization forward and make better products at the end of the day."